Clinical Trial Update: Home Based Daratumumab Administration for Patients With Multiple Myeloma [Phase 4]

View source ↗

Summary

Phase 4 study update on home-based administration of daratumumab for multiple myeloma, with the trial completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Plasma Cell Myeloma | Phase 4 | Status: COMPLETED | Results posted: 2025-11-21